ustekinumab
Ligand Summary
A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
ChEMBL: CHEMBL1201835
DrugCentral: 4966
LyCHI: ustekinumab
Target Activities
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
ANTIBODY BINDING | ||||||
ANTIBODY BINDING | ||||||
ANTIBODY BINDING | ||||||